Skip to main content

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Latest https://ift.tt/36lyTbO
Labels:

Comments

Post a Comment

Popular posts from this blog

Don’t Let the A.I. Optimists Fool You

By Unknown Author from NYT Opinion https://ift.tt/fQLoEc9
Post a Comment
Read more

Brennan and Clapper: Let’s Set the Record Straight on Russia and 2016

By John O. Brennan and James Clapper from NYT Opinion https://ift.tt/UGHIm0E
Post a Comment
Read more